Core mission evidenced by LEAPS-INNOV, CALIPSOplus, Sylinda, BEATS, OPEN SESAME, ARIES, XLS, and AMaChaS — all centered on light source infrastructure and beamline development.
CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON
Operator of the ALBA Synchrotron near Barcelona, providing advanced X-ray and photon-based analytical services for research and industry across Europe.
Their core work
ALBA-CELLS operates the ALBA Synchrotron Light Source near Barcelona, one of Europe's major photon science facilities. They provide beamline access to researchers and industry users for advanced material characterization, structural biology, environmental analysis, and cultural heritage studies using synchrotron radiation techniques. Beyond running the facility, they actively support capacity building across Europe and the Middle East, train next-generation scientists, and increasingly work to transfer synchrotron-based analytical methods to industrial applications.
What they specialise in
iNEXT-Discovery (NMR, EM, crystallography for drug discovery), CoCID (cell imaging, nanoCT), NANOCANCER (radio-sensitization), and OPEN SESAME (life sciences beamlines).
Sylinda focuses explicitly on synchrotron light industry applications, LEAPS-INNOV on open innovation with industry, and RI Impact Pathways on measuring socio-economic returns.
ExPaNDS project focused on EOSC-integrated data services, FAIR metadata catalogues, and community training for photon and neutron research infrastructures.
Recurring keyword across OPEN SESAME, BEATS, and Sylinda — synchrotron techniques applied to environmental samples and heritage objects.
EuroCirCol (circular collider study) and XLS (CompactLight) — contributing accelerator physics expertise to next-generation machine design.
How they've shifted over time
In the early H2020 period (2014–2018), ALBA-CELLS focused on public engagement, researcher training, and building international scientific communities — projects like OurFuture (researchers' night), OPEN SESAME (Middle East capacity building), and DOC-FAM (doctoral training). From 2019 onward, the focus shifted decisively toward industrial applications of synchrotron light, socio-economic impact measurement, and open data infrastructure — exemplified by Sylinda (industry users), LEAPS-INNOV (open innovation), and ExPaNDS (EOSC data services). The trajectory is clear: from a facility that primarily served academic researchers to one actively positioning itself as a technology partner for industry.
ALBA-CELLS is actively building bridges between its synchrotron capabilities and industrial end-users, making it an increasingly relevant partner for applied R&D projects that need advanced material characterization.
How they like to work
ALBA-CELLS operates overwhelmingly as a participant (14 of 17 projects), which is typical for large research infrastructures that provide facility access and specialized expertise to consortia rather than leading them. They have coordinated only twice — NANOCANCER (a Marie Curie fellowship) and AMaChaS (material characterization) — both relatively small, focused projects. With 130 unique partners across 31 countries, they function as a well-connected hub in the European research infrastructure network, making them easy to integrate into new consortia.
ALBA-CELLS has collaborated with 130 unique partners across 31 countries, reflecting their role as a pan-European research infrastructure. Their network spans from Western European light source facilities to Middle Eastern institutions (via OPEN SESAME and BEATS with SESAME in Jordan).
What sets them apart
ALBA-CELLS is one of a small number of synchrotron facilities in Southern Europe, giving it a geographic advantage for Mediterranean and Middle Eastern collaborations. Unlike purely academic light sources, they have explicitly invested in industrial access programs (Sylinda, LEAPS-INNOV), meaning they can offer companies direct beamtime and analytical support — not just research papers. Their combination of structural biology beamlines, environmental analysis capabilities, and accelerator design expertise makes them a versatile infrastructure partner across multiple scientific domains.
Highlights from their portfolio
- LEAPS-INNOVTheir largest funded project (EUR 604,720), focused on open innovation between European light sources and industry — signals their strategic direction.
- BEATSBuilt a tomography beamline at SESAME in Jordan, demonstrating ALBA's role in international science diplomacy and capacity building beyond Europe.
- iNEXT-DiscoveryMajor structural biology infrastructure project (EUR 310,888) providing transnational access for drug discovery and health research — their strongest life sciences engagement.